Market Overview:
The global single-dose prefilled cartridges market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for single-dose prefilled cartridges from various application segments such as cancer, vaccines, pain management, hematological disorders, rheumatic disorders and others. In addition, the growing preference for disposable prefilled cartridges over reusable ones is also contributing significantly to the growth of this market. Regionally, North America dominates the global single-dose prefilled cartridges market followed by Europe and Asia Pacific.
Product Definition:
A single-dose prefilled cartridge is a medical device that contains a fixed dose of medication. The cartridge is inserted into an injection pen, which delivers the medication under pressure. Single-dose cartridges are used to administer medications such as insulin, epinephrine, and glucagon. They are also used to deliver contrast media during medical procedures.
Reusable:
Reusable injectable drugs are those that are intended to be used multiple times. They can be single-use or multi-use, but the most commonly used ones are multidose cartridges and vials. Reusable products have been around for a long time; however, in recent years they have gained increased attention due to their cost effectiveness compared to disposable ones and this has led to an increase in market growth.
Disposable:
Single-dose prefilled cartridges are a new concept in the healthcare industry. They have been used extensively in the pharmaceutical industry for packaging and transporting multi-dose vials and ampoules of liquid or solid medications. The major advantage offered by single-dose prefilled cartridges is that they eliminate the need to measure out doses manually, which is highly prone to error.
Application Insights:
Cancer application dominated the global single-dose prefilled cartridges market with a revenue share of over 40.0% in 2017. This is attributed to the growing incidence of cancer and rising demand for oncology drugs across the globe, especially in developing countries such as India, China, Brazil and Mexico. For instance, according to data published by WHO in 2018 regarding cancer prevalence rates globally, it was estimated that around 1 in 6 women and 1 in 5 men are likely to develop cancer during their lifetime globally. Furthermore, an estimated 70 million people were diagnosed with new cases of lung cancer annually from 2012 to 2015 worldwide. These factors indicate a significant growth opportunity for market players catering to this segment over the forecast period which will be catered by injectable drugs such as insulinoma kinase (Ink) inhibitor protein (Iki) antibody combination therapy manufactured by Biogen Inc., Bristol-Myers Squibb Company LLC., Pfizer Canada Inc., Eli Lilly Canada Ltd.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to factors such as technological advancements, high disease burden, and increasing government initiatives for single-dose prefilled cartridges. For instance, in December 2016, CIVCO partnered with the U.S.-based company 3M to develop a single-use prefilled syringe that would reduce needle stick injuries and improve patient safety throughout North America.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to factors such as improving healthcare infrastructure due to rising investments from foreign players along with growing demand for cost-effective products from end users including hospitals & clinics.
Growth Factors:
- Increasing demand for single-dose prefilled cartridges from the biopharmaceutical and medical device industries for improved patient safety and reduced medication errors.
- Growing preference for single-dose prefilled cartridges over vials and syringes due to their ease of use, accuracy, and reliability.
- Technological advancements in the design of single-dose prefilled cartridges that improve performance and reduce manufacturing costs.
- Rising demand from emerging markets due to increasing population, rising income levels, and growing awareness about the benefits of using single-dose prefilled cartridges over other delivery methods.
Scope Of The Report
Report Attributes
Report Details
Report Title
Single-Dose Prefilled Cartridges Market Research Report
By Type
Reusable, Disposable
By Application
Cancer, Vaccines, Pain Management, Hematological Disorders, Rheumatic Disorders, Others
By Companies
Amgen, Teva Pharmaceutical, AstraZeneca, Mylan, Pfizer, Fresenius Kabi, Novartis, Sanofi, Merck
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Single-Dose Prefilled Cartridges Market Report Segments:
The global Single-Dose Prefilled Cartridges market is segmented on the basis of:
Types
Reusable, Disposable
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer, Vaccines, Pain Management, Hematological Disorders, Rheumatic Disorders, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Amgen
- Teva Pharmaceutical
- AstraZeneca
- Mylan
- Pfizer
- Fresenius Kabi
- Novartis
- Sanofi
- Merck
Highlights of The Single-Dose Prefilled Cartridges Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Reusable
- Disposable
- By Application:
- Cancer
- Vaccines
- Pain Management
- Hematological Disorders
- Rheumatic Disorders
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Single-Dose Prefilled Cartridges Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Single-dose prefilled cartridges are a type of medication cartridge that is filled with a single dose of the medication. These cartridges are often used in place of multiple-dose prefilled cartridges, which can be more expensive.
Some of the major companies in the single-dose prefilled cartridges market are Amgen, Teva Pharmaceutical, AstraZeneca, Mylan, Pfizer, Fresenius Kabi, Novartis, Sanofi, Merck.
The single-dose prefilled cartridges market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Single-Dose Prefilled Cartridges Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Single-Dose Prefilled Cartridges Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Single-Dose Prefilled Cartridges Market - Supply Chain
4.5. Global Single-Dose Prefilled Cartridges Market Forecast
4.5.1. Single-Dose Prefilled Cartridges Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Single-Dose Prefilled Cartridges Market Size (000 Units) and Y-o-Y Growth
4.5.3. Single-Dose Prefilled Cartridges Market Absolute $ Opportunity
5. Global Single-Dose Prefilled Cartridges Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Single-Dose Prefilled Cartridges Market Size and Volume Forecast by Type
5.3.1. Reusable
5.3.2. Disposable
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Single-Dose Prefilled Cartridges Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Single-Dose Prefilled Cartridges Market Size and Volume Forecast by Application
6.3.1. Cancer
6.3.2. Vaccines
6.3.3. Pain Management
6.3.4. Hematological Disorders
6.3.5. Rheumatic Disorders
6.3.6. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Single-Dose Prefilled Cartridges Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Single-Dose Prefilled Cartridges Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Single-Dose Prefilled Cartridges Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Single-Dose Prefilled Cartridges Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Single-Dose Prefilled Cartridges Demand Share Forecast, 2019-2029
9. North America Single-Dose Prefilled Cartridges Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Single-Dose Prefilled Cartridges Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Single-Dose Prefilled Cartridges Market Size and Volume Forecast by Application
9.4.1. Cancer
9.4.2. Vaccines
9.4.3. Pain Management
9.4.4. Hematological Disorders
9.4.5. Rheumatic Disorders
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Single-Dose Prefilled Cartridges Market Size and Volume Forecast by Type
9.7.1. Reusable
9.7.2. Disposable
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Single-Dose Prefilled Cartridges Demand Share Forecast, 2019-2029
10. Latin America Single-Dose Prefilled Cartridges Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Single-Dose Prefilled Cartridges Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Single-Dose Prefilled Cartridges Market Size and Volume Forecast by Application
10.4.1. Cancer
10.4.2. Vaccines
10.4.3. Pain Management
10.4.4. Hematological Disorders
10.4.5. Rheumatic Disorders
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Single-Dose Prefilled Cartridges Market Size and Volume Forecast by Type
10.7.1. Reusable
10.7.2. Disposable
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Single-Dose Prefilled Cartridges Demand Share Forecast, 2019-2029
11. Europe Single-Dose Prefilled Cartridges Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Single-Dose Prefilled Cartridges Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Single-Dose Prefilled Cartridges Market Size and Volume Forecast by Application
11.4.1. Cancer
11.4.2. Vaccines
11.4.3. Pain Management
11.4.4. Hematological Disorders
11.4.5. Rheumatic Disorders
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Single-Dose Prefilled Cartridges Marke Size and Volume Forecast by Type
11.7.1. Reusable
11.7.2. Disposable
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Single-Dose Prefilled Cartridges Demand Share, 2019-2029
12. Asia Pacific Single-Dose Prefilled Cartridges Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Single-Dose Prefilled Cartridges Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Single-Dose Prefilled Cartridges Market Size and Volume Forecast by Application
12.4.1. Cancer
12.4.2. Vaccines
12.4.3. Pain Management
12.4.4. Hematological Disorders
12.4.5. Rheumatic Disorders
12.4.6. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Single-Dose Prefilled Cartridges Market Size and Volume Forecast by Type
12.7.1. Reusable
12.7.2. Disposable
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Single-Dose Prefilled Cartridges Demand Share, 2019-2029
13. Middle East & Africa Single-Dose Prefilled Cartridges Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Single-Dose Prefilled Cartridges Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Single-Dose Prefilled Cartridges Market Size and Volume Forecast by Application
13.4.1. Cancer
13.4.2. Vaccines
13.4.3. Pain Management
13.4.4. Hematological Disorders
13.4.5. Rheumatic Disorders
13.4.6. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Single-Dose Prefilled Cartridges Market Size and Volume Forecast by Type
13.7.1. Reusable
13.7.2. Disposable
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Single-Dose Prefilled Cartridges Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Single-Dose Prefilled Cartridges Market: Market Share Analysis
14.2. Single-Dose Prefilled Cartridges Distributors and Customers
14.3. Single-Dose Prefilled Cartridges Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Amgen
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Teva Pharmaceutical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. AstraZeneca
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Mylan
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Pfizer
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Fresenius Kabi
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Novartis
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Sanofi
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Merck
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
